Companies /Healthcare

Pfizer Inc

NYSE: PFE Drug Manufacturers - General
$27.96
▼ $0.34 (−1.20%) today
Markets open · 4:00pm ET

PFE Coverage

Page 81
6:43am ET
Media

Media Digest (5/2/2012) Reuters, WSJ, NYT, FT

Moody’s warns that Japan’s finances will be hurt if it cannot get acceptance of a new sales tax. (Reuters) New Chinese factory data indicate that the industry’s activity may have bottomed. (Reuters)…

Douglas A. McIntyre
8:32am ET
Investing

Stock Upgrades And Downgrades

Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Canaccord  also reiterated its buy rating on Watson Pharmaceuticals (WPI: NYSE) Goldman Sachs upgraded Community Health Systems (NYSE:…

Douglas A. McIntyre
6:31am ET
Investing

Pfizer Dumps Baby Food On Nestle

Pfizer (NYSE: PFE) wanted out of the baby nutrition business and found a ready buyer for the division that owns its operations in that industry. There has been a rumor that Nestle has…

PFE
Douglas A. McIntyre
6:37am ET
Media

Media Digest (3/2/2012) Reuters, WSJ, FT, Bloomberg

Anheuser-Busch InBev NV may buy China’s Kingway Brewery Holdings’ assets. (Reuters) The Department of Justice is expected to widen its probe of mortgage-backed securities. (Reuters) AT&T (NYSE: T) sets new standards that will impose penalties…

Douglas A. McIntyre
6:11pm ET
Investing

FDA-Use Of Statins May Cause Problems

The FDA announced today that the use of statins, common among people with high cholesterol, pose problems which were not mentioned on the lables on the drugs before. The agency reported that…

Douglas A. McIntyre